Related Experiment Videos
Heart period variability during vagal nerve stimulation
A B Setty1, B V Vaughn, S R Quint
1Department of Neurology, University of North Carolina, Chapel Hill 27599-7025, USA.
Seizure
|August 13, 1998
Summary
Vagal nerve stimulation (VNS) for epilepsy showed no significant acute effects on heart rhythm or heart period variability in patients. This emerging therapy appears safe for cardiac function in the short term.
Area of Science:
- Neuroscience
- Cardiology
- Medical Technology
Background:
- Vagal nerve stimulation (VNS) is an emerging therapy for intractable epilepsy.
- The impact of VNS on cardiac function, specifically heart period variability, remains largely unknown.
Purpose of the Study:
- To investigate the acute effects of high-frequency, high-intensity left vagal nerve stimulation on heart period variability in epilepsy patients.
Main Methods:
- Electrocardiogram (ECG) data were collected from 10 epilepsy patients during baseline, VNS, and post-stimulation periods.
- Analysis included average heart period, R-R interval changes, fractal dimension, and power spectral analysis of heart rate variability.
Main Results:
- No significant changes were observed in average heart period, R-R interval variability, or fractal dimension during VNS.
- Total power in specific frequency bands (0.0-0.04 Hz, 0.04-0.12 Hz, 0.2-0.4 Hz) remained unchanged.
Conclusions:
- Left vagal nerve stimulation demonstrates minimal acute impact on cardiac rhythm and heart period variability.
- These findings suggest VNS may be safe concerning short-term cardiac effects in epilepsy management.